A research team at the University of New Mexico (UNM), Albuquerque, is moving forward with the development of a vaccine against tauopathies, a neurodegenerative class of diseases that includes Alzheimer's disease, but while promising in the lab, it could take a decade to get an actual vaccine to market.

BOGOTA, Colombia – A panel of experts is raising concerns about spotty access to biologics – and eventually biosimilars – across Latin America to treat multiple sclerosis (MS). Their concerns are linked to patient access, pricing, regulations and reporting, and also stem, in part, from the fragmented nature of the continent. Latin America has a population of 626 million scattered across 33 different markets with just as many regulatory structures.

BOGOTA, Colombia – As a first step to reach out to international markets, Mannkind Corp., of Westlake Village, Calif., has received a green light to market Afrezza, its insulin inhalation powder, in Brazil.

BOGOTA, Colombia - Gilead Sciences Inc. is facing a somewhat complicated judicial challenge in Brazil to its patent for hepatitis C drug Sovaldi (sofosbuvir).